Stein, A. S., Watson, D., Nair, P. R., Basu, K., Ullal, Y. S., Ghosh, A., . . . Marcucci, G. (2020). Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02. Blood, 136(Supplement 1), 9-10. https://doi.org/10.1182/blood-2020-142214
Chicago Style (17th ed.) CitationStein, Anthony S., et al. "Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02." Blood 136, no. Supplement 1 (2020): 9-10. https://doi.org/10.1182/blood-2020-142214.
MLA (9th ed.) CitationStein, Anthony S., et al. "Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02." Blood, vol. 136, no. Supplement 1, 2020, pp. 9-10, https://doi.org/10.1182/blood-2020-142214.